Magnetic resonance imaging abnormalities in the corpus callosum of a patient with neuropsychiatric lupus

Neurologist

Volumn 12, Issue 5, 2006, Pages 271-273

  Fogel, Brent ^a,b   Cardenas, Doris ^a   Ovbiagele, Bruce ^a  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Corpus callosum; Lupus; Magnetic resonance imaging; Psychosis; Splenium

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; PHENYTOIN; PREDNISONE;

ADULT; ARTICLE; BEHAVIOR CHANGE; BRAIN DAMAGE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORPUS CALLOSUM ABNORMALITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; FEMALE; GRAND MAL SEIZURE; HUMAN; LABORATORY TEST; NEUROIMAGING; NEUROPSYCHIATRIC LUPUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOSIS; RADIODIAGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; CORPUS CALLOSUM; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING;

EID: 33748975571     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000237119.00864.d7     Document Type: Article

References (16)

1. American College of Rheumatology. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599-608.
2. Moore P, Lisak RP. Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction. Springer Semin Immunopathol. 1995;17:43-60.
3. Doherty MJ, Jayadev S, Watson NF, et al. Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol. 2005;62:433-437.
4. Chrysikopoulos H, Andreou J, Roussakis A, et al. Infarction of the corpus callosum: computed tomography and magnetic resonance imaging. Eur J Radiol. 1997;25:2-8.
5. Friese S, Bitzer M, Freudenstein D, et al. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology. 2000;42:795-802.
6. Chason DP, Fleckenstein JL, Ginsburg MI, et al. Transient Splenial Edema in Epilepsy: MR Imaging Evaluation. Proceedings of the 34th Annual Meeting of the American Society of Neuroradiology; June 21-27 1996, Seattle, WA, USA. Chicago, IL: Old Smith Printers; 1996.
7. Kim S, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol. 1999;20:125-129.
8. Gurtler S, Ebner A, Tuxhorn I, et al. Transient lesion in the splenium of the corpus callosum and antiepileptic withdrawal. Neurology. 2005;65:1032-1036.
9. Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry. 2001;70:459-463.
10. Oster J, Doherty C, Grant PE, et al. Diffusion-weighted imaging abnormalities in the splenium after seizures. Epilepsia. 2003;44:852-854.
11. Sun K, Liu WT, Tsai CY, et al. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann Rheum Dis. 1992;51:707-712.
12. Hulshoff Pol HE, Schnack HG, Mandl RC, et al. Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage. 2004;21:27-35.
13. Diwadkar VA, DeBellis MD, Sweeney JA, et al. Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophrenia. Schizophr Res. 2004;67:277-282.
14. Shenton ME, Dickey CC, Frumin M, et al. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49:1-52.
15. Parraga HC, Parraga MI, Jensen AR. Cognitive, behavioral, psychiatric symptoms in two children with agenesis of the corpus callosum: case report. Int J Psychiatry Med. 2003;33:107-113.
16. Motomura N, Satani S, Inaba M. Monozygotic twin cases of the agenesis of the corpus callosum with schizophrenic disorder. Psychiatry Clin Neurosci. 2002;56:199-202.